Signify Premium Insight: Vendor Financials Roundup – The Health of the Imaging Sector Q4 2021

Although 2021 may seem a distant memory, vendors’ performances in its final quarter, along with the circumstances which shaped them, offer mixed fortunes for medical imaging’s biggest companies in 2022.

The quarter’s results showed some continuing reticence as a result of the coronavirus pandemic’s ongoing disruption, with new variants causing further headaches for vendors and providers alike. More broadly however, vendors’ results were mixed. Many fell into the ‘unremarkable’ category, such as Philip’s Diagnosis and Treatment business, and Nuance’s Healthcare business. These vendors were able to deliver low single-digit revenue growth over the quarter, enough to appease, but not delight, investors.